Skip to main content
SpringerLink
Log in

Endothelium, Lipoproteins and Atherosclerosis. Effects of Lipid Lowering and Lipid Modification Therapy

  • Chapter
Neurohumoral Regulation of Coronary Flow

Part of the book series: Developments in Cardiovascular Medicine ((DICM,volume 150))

  • 27 Accesses

Abstract

Cholesterol-lowering therapy has been proven to reduce total mortality in post myocardial infarct patients after 15 years of treatment with niacin1. In the Lipid Research Clinics’ study, the treatment with cholestyramin as primary prevention was associated with a lower incidence of angina pectoris and positive exercise tests2. In addition, the coronary artery regression study of Brown showed a reduction in adverse cardiac events in patients with angina treated with hypolipemica, which was as impressive as the regression of atherosclerosis in this group3.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Canner PL, Berge KG, Wenger NK et al. Fifteen year mortality in coronary drug project patients: long term benefit with niacin. J Am Coll Cardiol 1986;8:1245–55.

    Article  PubMed  CAS  Google Scholar 

  2. The Lipid Research Clinics Coronary Primary Prevention Trial result: I Reduction in incidence of coronary heart disease. J Am Med Assoc 1984;251:351–64.

    Google Scholar 

  3. Brown G, Alber JJ, Fischer LD et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 1990;323:1289–98.

    Article  CAS  Google Scholar 

  4. Watts GF, Lewis B, Brunt JNH et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas’ Atherosclerosis Regression Study (STARS) Lancet 1992;339:563–9.

    PubMed  CAS  Google Scholar 

  5. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992;326:242–9 and 310–8.

    Article  PubMed  CAS  Google Scholar 

  6. Ip JH, Fuster V, Badimon L, Badimon JJ, Taubman MB, Chesebro JH. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol 1990;15:1667–87.

    Article  PubMed  CAS  Google Scholar 

  7. Maseri A, Davies G, Hackett D, Kaski JC. Coronary artery spasm and vasoconstriction. The case for a distinction. Circulation 1990 81;6:1983–91.

    Article  PubMed  CAS  Google Scholar 

  8. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980;299:3773–6.

    Google Scholar 

  9. Lüscher TF. Endothelium-derived relaxing and contracting factors: potential role in coronary artery disease. Eur Heart J 1989;10:847–57.

    PubMed  Google Scholar 

  10. Nagao T, Vanhoutte PM. Endothelium-dependent relaxations resistant to nitro-l-arginine are mediated by endothelium-derived hyperpolarizations in porcine coronary arteries (abstract). FASEB J 1991;5:A1417.

    Google Scholar 

  11. Ludmer PL, Selwyn AP, Shook TL et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med 1986;315:1046–51.

    Article  PubMed  CAS  Google Scholar 

  12. Yasue H, Matsuyama K, Matsuyama K, Okumura K, Morikama Y, Ogawa H. Responses of angiographically normal human coronary arteries to intracoronary injection of acetylcholine by age and segment. Circulation 1990;81:482–90.

    Article  PubMed  CAS  Google Scholar 

  13. Golino P, Piscione F, Willerson JT et al. Divergent effects of serotonin on coronary artery dimensions and blood flow pattern in patients with coronary atherosclerosis and control patients. N Engl J Med 1991;324:641–8.

    Article  PubMed  CAS  Google Scholar 

  14. Mc Fadden EP, Clark JG, Davies GJ, Kaski JC, Haider AW, Maseri A. Effect of intracoronary serotonin on coronary vessels in patients with stable angina and patients with variant angina. N Engl J Med 1991;324:648–54.

    Article  CAS  Google Scholar 

  15. Zeiher AM, Drexler H, Wollschläger H, Just H. Modulation of coronary vasomotor tone in humans. Progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 1991;83:391–401.

    Article  PubMed  CAS  Google Scholar 

  16. Minor RL, Myers PR, Guerra R, Bates JN, Harrison DG. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest 1990;86:2109–16.

    Article  PubMed  CAS  Google Scholar 

  17. Hoeffner U, Boulanger C, Vanhoutte PM. Proximal and distal coronary arteries respond differently to basal EDRF but not to NO. Am J Physiol 1989;256:H828–31.

    Google Scholar 

  18. Lüscher TF, Rischard V, Tschudi M, Yang Z, Boulanger C. Endothelial control of vascular tone in large and small coronary areteries. J Am Coll Cardiol 1990;15:519–27.

    Article  PubMed  Google Scholar 

  19. Shimokawa H, Flavahan NA, Vanhoutte PM. Loss of endothelial pertussis toxin-sensitive G protein function in atherosclerotic porcine coronary arteries. Circulation 1991;83:652– 60.

    Article  PubMed  CAS  Google Scholar 

  20. Galle J, Mülsch, Busse R, Bassenge E. Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelium-derived relaxing factor. Arteriosclerosis and thrombosis 1991;11:198–203.

    Article  PubMed  CAS  Google Scholar 

  21. Tanner FC, Noll G, Boulanger CM, Lüscher TF. Oxidized low density lipoproteins inhibit relaxation of porcine cornary arteries. Circulation 1991;83:2012–20.

    Article  PubMed  CAS  Google Scholar 

  22. Kugiyama K, Kerns SA, Morrisett JD, Roberts R, Henry PD. Impairment of endothelium-dependent relaxation by lysolecithin in modified low-density lipoproteins. Nature 1990;344:160–2.

    Article  PubMed  CAS  Google Scholar 

  23. Flavahan NA. Atherosclerosis or lipoprotein-induced endothelial dysfunction. Circulation 1992;85:1927–38.

    Article  PubMed  CAS  Google Scholar 

  24. Cooke JP, Andon NA, Girerd XJ, Hirsch AT, Creager MA. Arginine restores cholinergic relaxation of hypercholesterolaemic rabbit aorta. Circulation 1991;83:1057–62.

    Article  PubMed  CAS  Google Scholar 

  25. Drexler H, Zeiher AM, Meinzer K, Just H. Correction of endothelial dysfunction in coronary microcirculation of hypercholesterolemic patients by L-arginine. Lancet 1991;228:1546–50.

    Article  Google Scholar 

  26. Mügge A, Harrison DG. L-arginine does not restore endothelial dysfunction in atherosclerotic rabbit aorta in vitro. Blood Vessels 1991;28:354–7.

    PubMed  Google Scholar 

  27. Minor RL, Myers PR, Guerra R, Bates JN, Harrison DG. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta, J Clin Invest 1990;86:2109–16.

    Article  PubMed  CAS  Google Scholar 

  28. Rubanyi GM, Vanhoutte PM. Superoxide anions and hyperoxia inactivate endothelium-derived relaxing factor Am J Physiol 1986; 250:H822–H7.

    Google Scholar 

  29. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991;43:109–42.

    PubMed  CAS  Google Scholar 

  30. Barth JD, Zonjee MMB, The Regress Research Group. Regression growth evaluation study (Regress): study design and baseline characteristics in 600 patients, Am J Cardiol 1992; 8(9): 925–32.

    CAS  Google Scholar 

  31. van Boven AJ, Viersma JW, Meyler FL, Lie Kl. Feasibility of reducing silent ischemia in patients with angina pectoris. J Amb Monit 1992; 5(suppl):133.

    Google Scholar 

  32. Stary HC. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis 1989;(suppl I) l–19-l–32.

    Google Scholar 

  33. Harrison DG, Armstrong ML, Freiman PC, Heistad DD. Restoration of endothelium-dependent relaxation by dietary treatment of atherosclerosis. J Clin Invest 1987;80:1808– 11.

    Article  PubMed  CAS  Google Scholar 

  34. Shimokawa H, Lam JYT, Chesebro JH, Bowie EJW, Vanhoutte PM. Effects of dietary supplementation with cod-liver oil on endothelium-dependent reponses in porcine coronary arteries. Circulation 1987;76:898–905.

    Article  PubMed  CAS  Google Scholar 

  35. Osborne JA, Leno PH, Siegfried MR, Stahl GL, Fusman B, Lefer AM. Cardiovascular effects or acute hypercholestrerolemia in rabbits. Reversal with Lovastatin treatment. J Clin Invest 1989;83:465–73.

    Article  PubMed  CAS  Google Scholar 

  36. Steinberg D and Workshop Participants. Antioxidants in the prevention of human atherosclerosis. Circulation 1992;85:2337–44.

    Article  PubMed  CAS  Google Scholar 

  37. Carew TE, Schwenke DC, Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrofage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci USA 1987;84:7725–9.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. A. J. van Boven MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. W. Jukema MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Clinical Pharmacology, University Hospital Groningen, Groningen, The Netherlands

    W. H. van Gilst

  2. Department of Cardiology Thorax-Center, University Hospital Groningen, Groningen, The Netherlands

    K. I. Lie

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

van Boven, A.J., Jukema, J.W. (1993). Endothelium, Lipoproteins and Atherosclerosis. Effects of Lipid Lowering and Lipid Modification Therapy. In: van Gilst, W.H., Lie, K.I. (eds) Neurohumoral Regulation of Coronary Flow. Developments in Cardiovascular Medicine, vol 150. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-1900-9_8

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-1900-9_8

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-4839-2

  • Online ISBN: 978-94-011-1900-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation